Biotechnology
Picosun's Medical ALD Solutions Ensure Excellent Hermetic Encapsulation
ESPOO, Finland, June 29, 2020 /PRNewswire/ -- Picosun Group reports excellent results in ALD-organic bilayer encapsulation of metal electrodes for neuroprosthetics and bioelectronic medicine. Group also reports superior hermetic barrier performance of its ALD nanolaminates against corrosive ion ...
2020-06-29 11:34
1299
Philogen Received Clinical Trial Authorisation With Nidlegy in Nonmelanoma Skin Cancer
SIENA, Italy, June 26, 2020 /PRNewswire/ -- Philogen S.p.A., a privately-owned biotechnology company, is pleased to announce that the Swiss national competent authority Swissmedic issued the authorization to run a clinical phase II study in patients with locally advanced, not metastatic nonmelano...
2020-06-26 15:00
1737
ERBA Mannheim Launches CE Marked COVID-19 IgM Antibody ELISA
LONDON, June 25, 2020 /PRNewswire/ -- In response to the ongoing COVID-19 pandemic,Erba Mannheim today launched the ErbaLisa COVID-19 IgM ELISA kit for detection of IgM antibodies to SARS-CoV-2. IgM antibodies are produced first and detectable during disease onset, so using the new assay in comb...
2020-06-25 01:08
3118
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2020 Financial Results
HONG KONG, June 24, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results fo...
2020-06-24 19:30
14561
Philogen Received Combination Pack Approval for Nidlegy
SIENA, Italy, June 24, 2020 /PRNewswire/ -- Philogen S.p.A., a privately-owned biotechnology company, is pleased to announce that, onJan. 30, 2020, EMA's CHMP expressed a favorable opinion to the request of a combination pack for the to-be-marketed pharmaceutical form of NidlegyTM, a combination ...
2020-06-24 15:00
1267
Akeso Appoints Prof. Bradley Monk as Lead Gynecologic Oncology Advisor and Chair of the Steering Committee
LOS ANGELES, June 24, 2020 /PRNewswire/ -- Akeso, Inc. ("Akeso", 9926.HK) announced the appointment of ProfessorBradley J. Monk, MD, FACOG[1], FACS[2] as Lead Gynecologic Oncology Advisor and Chair of the Steering Committee for its global Phase 2, multicentre registration study to evaluate the ef...
2020-06-24 12:55
7227
InxMed Released Research Data of "FAK inhibitor IN10018 overcomes drug resistance of KRAS G12C inhibition" at 2020 AACR Annual Meeting
SHANGHAI, June 24, 2020 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, announced that the company has released the research data of "FAK inhibitor IN10018...
2020-06-24 08:41
2113
IgNova Files Patent Application on Antibody Against COVID-19
VISBEK, Germany, June 24, 2020 /PRNewswire/ -- IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (I...
2020-06-24 02:13
1649
Greater cfDNA Recovery May Help Accelerate Development of Cancer Liquid Biopsy Applications
HONG KONG, June 23, 2020 /PRNewswire/ -- PHASE Scientific, a high-growth biotechnology company that develops innovative sample preparation technologies, announced new findings at the American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting II. The study presented by MD Anderson...
2020-06-23 09:00
2435
Kazia Presents Further Paxalisib and Cantrixil Data at AACR, Reinforcing Positive Efficacy Signals for both Drugs
SYDNEY, June 22, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share poster presentations of interim data from the ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most com...
2020-06-22 12:39
4145
Qiming's Portfolio Company SinocellTech Lands on STAR Market
SHANGHAI, June 22, 2020 /PRNewswire/ -- Chinese biologic drug developer SinocellTech, Qiming's portfolio company, today lands on the Science and Technology Innovation Board (the STAR Market). The issue price of SinocellTech (SHSE: 688520) isCNY 25.64 per share. The stock opens at CNY 85 per share...
2020-06-22 12:20
2446
Innovent Announces The Stock Exchange of Hong Kong Limited Approved the "B" Marker Removal from the Company's Stock Symbol in the HKEX
SUZHOU, China, June 22, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announc...
2020-06-22 07:40
6159
Ascentage Pharma Enters Clinical Collaboration to Evaluate the Combination of Bcl-2 and BTK Inhibitors
SUZHOU, China and ROCKVILLE, Md., June 22, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and senescence diseases, today announced a clinical collaboration with Acerta P...
2020-06-22 07:15
2931
Embrace Change to Turn Challenges into Opportunities: WuXi Biologics Successfully Hosted the 2nd Investor Day
SHANGHAI, June 19, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that its 2nd Investor Day with the theme of "Embrace Change to Turn Challenges into Opportunities", was successfully held onJune 18. T...
2020-06-19 17:56
2097
Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China
SUZHOU, China, June 19, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announc...
2020-06-19 12:20
10951
Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing
AGC Biologics produces humanized monoclonal antibody targeting IL-15 SEATTLE, June 18, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), produces a GMP-grade clinical batch of CALY-002 forCalypso Biotech. The immunotherapy biot...
2020-06-18 19:00
2520
IONpath appoints Brad Nelson to its leadership team as Senior Vice President of Marketing and Corporate Strategy
MENLO PARK, California, June 17, 2020 /PRNewswire/ -- IONpath, Inc. the leader in multiplexed spatial tissue imaging and analysis, today announced the appointment ofBrad Nelson to the position of Senior Vice President of Marketing and Corporate Strategy. Mr. Nelson will lead marketing, product ma...
2020-06-17 21:07
3426
InDevR Delivers Commercial Multiplex Coronavirus SeroAssay Kit and Testing Services for Vaccine Development
BOULDER, Colorado, June 17, 2020 /PRNewswire/ -- InDevR, Inc., a leader in novel analytical technologies that support the development and production of vaccines and biotherapeutics, announced commercial availability of its COVID-19 serology test kits. InDevR's VaxArray Coronavirus SeroAssay lever...
2020-06-17 20:00
1527
Viva BioInnovator (VBI) Successfully Held 1st Demo Day
SHANGHAI, June 15, 2020 /PRNewswire/ -- On 11 June 2020, Viva BioInnovator (VBI) successfully held its 1st Demo Day e-congress. Among nearly 50 incubation portfolio companies from the VBI platform, 8 startup companies attended this event, namely Forkhead Bio Therapeutics, DTx Pharma, Epican Techn...
2020-06-17 16:40
2216
Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine
AGC Biologics will manufacture SARS-CoV-2 vaccine for partner Saiba AG SEATTLE, June 16, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), has announced it will be partnering withSaiba AG to manufacture a SARS-CoV-2 vaccine to ...
2020-06-16 19:00
2745
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 293 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Transformation of Asia's Process Industries To Get A Boost Through Region's First Dedicated Process Technology Show
[Picked up by 279 media titles]
2024-11-12 16:00
Most Read
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
2024-11-11 21:00
5646
DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam
2024-11-08 20:11
5573
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
2024-11-12 09:00
5560
HOIANA RESORT & GOLF LAUNCHES PREMIUM HOIANA PICKLEBALL COURT
2024-11-08 00:18
5536
